tiprankstipranks
Trending News
More News >
China Innovation Investment Limited (HK:1217)
:1217
Hong Kong Market
Advertisement

China Innovation Investment Limited (1217) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1217

China Innovation Investment Limited

(1217)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 4o)
Rating:57Neutral
Price Target:
HK$0.02
▼(-20.00% Downside)
The overall stock score is driven by a strong balance sheet and reasonable valuation. However, concerns about cash flow stability and neutral technical indicators moderate the score. The lack of earnings call data and corporate events limits additional insights.
Positive Factors
Revenue Growth
Substantial revenue growth indicates strong market demand and effective investment strategies, enhancing long-term business prospects.
Strong Balance Sheet
A strong balance sheet with low financial leverage provides stability and flexibility for future investments and growth initiatives.
Gross Profit Margin
A high gross profit margin suggests efficient cost management and the ability to generate profits, supporting long-term financial health.
Negative Factors
Cash Flow Management
Poor cash flow management can lead to liquidity issues, affecting the company's ability to sustain operations and invest in growth.
Revenue and Net Income Volatility
Volatility in financial performance can undermine investor confidence and complicate strategic planning, impacting long-term growth.
Cash Flow Risks
Persistent negative cash flows can strain resources, limiting the company's ability to fund new investments and manage debt obligations.

China Innovation Investment Limited (1217) vs. iShares MSCI Hong Kong ETF (EWH)

China Innovation Investment Limited Business Overview & Revenue Model

Company DescriptionChina Innovation Investment Limited invests in equity-related securities and debt instruments in listed and unlisted companies in Hong Kong and the People's Republic of China. It also engages in transactions comprising options and futures that are traded on recognized securities or futures exchanges and for the purpose of hedging. The company invests in information technology, telecommunications, manufacturing, service, property, infrastructure, life science, and environmental sectors. China Innovation Investment Limited, formerly nown as Sino Technology Investments Company Limited, was incorporated in 2002 and is based in Sheung Wan, Hong Kong.
How the Company Makes MoneyChina Innovation Investment Limited generates revenue through a diversified investment portfolio, focusing on equity stakes in high-potential companies within innovative sectors. Its revenue model primarily includes capital appreciation from its investments, as well as potential dividends received from portfolio companies. The company may also earn management fees from funds it manages and performance fees based on the returns generated for its investors. Significant partnerships with other investment firms and strategic alliances in targeted industries contribute to its earnings by providing access to additional resources and opportunities for collaboration.

China Innovation Investment Limited Financial Statement Overview

Summary
The company has shown strong revenue growth and profit margins in 2024, but historical volatility and poor cash flow management raise concerns about sustainability. The balance sheet is robust with low leverage, but the lack of cash flow stability is a significant risk.
Income Statement
35
Negative
The company has shown significant revenue growth from 2023 to 2024, with a 549.5% increase. Gross profit margin is strong at 100%, indicating all revenue is contributing to profit. However, the historical volatility in revenue and net income, especially losses in 2021, raises concerns about stability. The net profit margin of 24.7% in 2024 is positive, but past inconsistencies impact the score.
Balance Sheet
75
Positive
The balance sheet is strong with a high equity ratio of 98.9% in 2024, indicating low financial leverage and a solid financial structure. The debt-to-equity ratio is minimal at 0.3%, reflecting low risk from debt obligations. The return on equity for 2024 is 0.9%, suggesting moderate efficiency in utilizing shareholder equity to generate profits.
Cash Flow
20
Very Negative
The cash flow statement shows a concerning lack of operating, investing, and financing cash flows in 2024, indicating potential issues with cash management or reporting. The absence of free cash flow growth and a historical pattern of negative cash flows highlight risks in liquidity and operational efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue39.24M20.26M3.12M34.38M-26.73M-3.64M
Gross Profit39.24M20.26M9.53M12.16M-27.62M-4.55M
EBITDA19.70M5.91M3.24M6.64M-32.94M-9.03M
Net Income19.97M5.00M2.19M5.76M-34.01M-9.81M
Balance Sheet
Total Assets616.73M548.58M550.22M564.03M612.68M656.35M
Cash, Cash Equivalents and Short-Term Investments323.35M299.84M177.96M137.63M156.54M225.14M
Total Debt934.00K1.38M2.23M475.00K1.39M2.26M
Total Liabilities50.95M5.87M2.55M770.00K1.68M2.60M
Stockholders Equity565.78M542.71M547.67M563.26M611.00M653.75M
Cash Flow
Free Cash Flow9.13M178.84M28.56M-15.37M-19.35M-1.77M
Operating Cash Flow9.13M178.84M28.62M-14.95M-19.35M-1.77M
Investing Cash Flow-8.56M-4.97M6.18M9.14M16.79M6.78M
Financing Cash Flow-880.00K-854.00K-883.00K-915.00K-871.00K-894.00K

China Innovation Investment Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.02
Price Trends
50DMA
0.02
Positive
100DMA
0.01
Positive
200DMA
0.01
Positive
Market Momentum
MACD
<0.01
Negative
RSI
54.02
Neutral
STOCH
183.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1217, the sentiment is Positive. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.01, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.02 is Neutral, neither overbought nor oversold. The STOCH value of 183.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1217.

China Innovation Investment Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
65
Neutral
HK$52.14M4.3612.66%64.51%104.35%
57
Neutral
HK$192.02M9.383.56%38.96%700.00%
45
Neutral
HK$553.65M54.5111.27%99.09%
41
Neutral
HK$223.30M-14.139.10%66.31%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1217
China Innovation Investment Limited
0.02
0.01
100.00%
HK:2312
China Financial Leasing Group Ltd
1.24
1.12
933.33%
HK:0310
Prosperity Investment Holdings Limited
0.16
0.06
60.00%
HK:0033
International Genius Company
0.40
-2.09
-83.94%
HK:0768
UBA Investments Ltd.
0.04
0.01
33.33%
HK:0080
China New Economy Fund Ltd.
0.40
0.30
300.00%

China Innovation Investment Limited Corporate Events

China Innovation Partners with Jiangsu Lizhuo for AI in Agriculture
Nov 12, 2025

China Innovation Investment Limited has entered into a strategic investment framework agreement with Jiangsu Lizhuo Information Technology Co., Ltd. to promote the application of artificial intelligence in agriculture. This collaboration aims to leverage Jiangsu Lizhuo’s technological strengths to expand its market presence and develop integrated AI solutions for agriculture, with plans for nationwide and overseas expansion, particularly in Southeast Asia and the Belt and Road regions.

China Innovation Investment Limited Announces Partial Offer for Elife Holdings Shares
Nov 4, 2025

China Innovation Investment Limited has announced the despatch of an offer document related to a voluntary conditional cash partial offer by Mango Financial Limited to acquire 180,000,000 shares in Elife Holdings Limited. This move is part of a series of announcements made by the company throughout 2025. The offer document, which includes terms and conditions of the partial offer, has been sent to shareholders and is available on the Stock Exchange’s website. The timetable for the offer is outlined, with key dates for acceptance and announcement of results specified, indicating a strategic move to potentially increase its stake in Elife Holdings Limited.

China Innovation Investment Limited Reports Net Asset Value Update
Oct 13, 2025

China Innovation Investment Limited announced that its unaudited net asset value per share as of September 30, 2025, was approximately HK$0.047. This financial update provides stakeholders with insight into the company’s current financial standing, which may influence investor confidence and market perception.

China Innovation Investment Limited Announces EGM for Strategic Acquisition
Oct 8, 2025

China Innovation Investment Limited has announced an extraordinary general meeting (EGM) to be held on October 28, 2025, in Hong Kong. The meeting will consider a resolution regarding a conditional voluntary partial cash offer by Mango Financial Limited, on behalf of China Innovation Investment Limited, to acquire a significant portion of shares in Elife Holdings Limited. This strategic move aims to strengthen the company’s market position and influence within the industry.

China Innovation Investment Limited Reports Net Asset Value Update
Sep 12, 2025

China Innovation Investment Limited announced that its unaudited net asset value per share was approximately HK$ 0.045 as of 31 August 2025. This financial update provides stakeholders with insights into the company’s current valuation, potentially impacting investor perceptions and market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025